High Acceptability of a Vaginal Ring Intended as a Microbicide Delivery Method for HIV Prevention in African Women

被引:75
|
作者
van der Straten, A. [1 ,2 ]
Montgomery, E. T. [1 ]
Cheng, H. [1 ]
Wegner, L. [1 ]
Masenga, G. [3 ]
von Mollendorf, C. [4 ]
Bekker, L. [5 ,6 ]
Ganesh, S. [7 ]
Young, K. [8 ]
Romano, J. [9 ]
Nel, A. [8 ]
Woodsong, C. [8 ]
机构
[1] RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA
[2] Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA USA
[3] Kiliminjaro Christian Med Ctr, Moshi, Tanzania
[4] Wits Reprod Hlth & HIV Res Inst, Johannesburg, South Africa
[5] Univ Cape Town, ZA-7925 Cape Town, South Africa
[6] Desmond Tutu HIV Fdn, Cape Town, South Africa
[7] S African MRC, Durban, South Africa
[8] Int Partnership Microbicides, Paarl, South Africa
[9] NWJ Grp LLC, Wayne, PA USA
关键词
Vaginal ring; Microbicide; HIV/STI prevention; Acceptability; Africa; INTRAVAGINAL RINGS; CONTRACEPTIVE USE; SAFETY;
D O I
10.1007/s10461-012-0215-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Vaginal rings (VRs) are new methods for continuous delivery of microbicides. This is the first study to quantitatively and qualitatively explore the acceptability of rings in Africa: 157 HIV-negative, sexually active women aged 18-35 used a placebo silicone elastomer ring for 12 weeks. They completed product acceptability questionnaires every 4 weeks. We conducted 6 exit focus group discussions with a subset of 48 women and 19 in-depth interviews with male partners. Retention in the study was high (97 %). Initial insertion at the clinic was successful on first attempt for 81 % of participants. Most women were comfortable using the ring, and very few (a parts per thousand currency sign2 %) could feel it during daily activities or had ring-related physical or emotional problems. In the qualitative interviews many participants reported that they initially had concerns about using the ring. However, only a minority of women actually reported concerns with the ring during the study. The most frequent concern was that the ring would get lost inside the body (20 %), and this was significantly correlated with study site, frequently thinking about the ring and reporting that the ring was not very easy to remove. Qualitative data suggest that informants grew to like the ring because it felt securely placed, was unnoticeable during daily activities, and felt "normal" during sex. The ring appeared to be highly acceptable for women and men. Initial concerns with this novel method suggest a need for enhanced product counseling when VRs are introduced.
引用
收藏
页码:1775 / 1786
页数:12
相关论文
共 50 条
  • [41] Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women
    Nel, Annalene A.
    Coplan, Paul
    van de Wijgert, Janneke H.
    Kapiga, Saidi H.
    von Mollendorf, Claire
    Geubbels, Eveline
    Vyankandondera, Joseph
    Rees, Helen V.
    Masenga, Gileard
    Kiwelu, Ireen
    Moyes, Jocelyn
    Smythe, Shanique C.
    AIDS, 2009, 23 (12) : 1531 - 1538
  • [42] Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs
    Cunha-Reis, Cassilda
    Machado, Alexandra
    Barreiros, Luisa
    Araujo, Francisca
    Nunes, Rute
    Seabra, Vitor
    Ferreira, Domingos
    Segundo, Marcela A.
    Sarmento, Bruno
    das Neves, Jose
    JOURNAL OF CONTROLLED RELEASE, 2016, 243 : 43 - 53
  • [43] Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide
    Woolfson, A. David
    Malcolm, R. Karl
    Morrow, Ryan J.
    Toner, Clare F.
    McCullagh, Stephen D.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 325 (1-2) : 82 - 89
  • [44] Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial
    Pleasants, E.
    Tauya, T.
    Reddy, K.
    Mirembe, B. G.
    Woeber, K.
    Palanee-Phillips, T.
    Zimba, C.
    Atujuna, M.
    Montgomery, E. T.
    Baeten, Jared
    Palanee-Phillips, Thesla
    Brown, Elizabeth
    Soto-Torres, Lydia
    Schwartz, Katie
    Makanani, Bonus
    Martinson, Francis
    Bekker, Linda-Gail
    Govender, Vaneshree
    Siva, Samantha
    Gaffoor, Zakir
    Naidoo, Logashvari
    Pather, Arendevi
    Jeenarain, Nitesha
    Nair, Gonasagrie
    Palanee-Phillips, Thesla
    Matovu, Flavia
    Mgodi, Nyaradzo
    Mhlanga, Felix
    AIDS AND BEHAVIOR, 2020, 24 (03) : 866 - 880
  • [45] Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness
    Glaubius, Robert
    Ding, Yajun
    Penrose, Kerri J.
    Hood, Greg
    Engquist, Erik
    Mellors, John W.
    Parikh, Urvi M.
    Abbas, Ume L.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (05)
  • [46] Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe
    Duby, Zoe
    Katz, Ariana W. K.
    Browne, Erica N.
    Mutero, Prisca
    Etima, Juliane
    Zimba, Chifundo Colleta
    Woeber, Kubashni
    Atujuna, Millicent
    Reddy, Krishnaveni
    van der Straten, Ariane
    AIDS AND BEHAVIOR, 2020, 24 (02) : 617 - 628
  • [47] The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy
    Céline Schurmans
    Irith De Baetselier
    Evelyne Kestelyn
    Vicky Jespers
    Thérèse Delvaux
    Stephen K Agaba
    Harry van Loen
    Joris Menten
    Janneke van de Wijgert
    Tania Crucitti
    BMC Public Health, 15
  • [48] The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy
    Schurmans, Celine
    De Baetselier, Irith
    Kestelyn, Evelyne
    Jespers, Vicky
    Delvaux, Therese
    Agaba, Stephen K.
    van Loen, Harry
    Menten, Joris
    van de Wijgert, Janneke
    Crucitti, Tania
    BMC PUBLIC HEALTH, 2015, 15
  • [49] The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention
    Ham, Anthony S.
    Nugent, Sean T.
    Peters, Jennifer J.
    Katz, David F.
    Shelter, Cory M.
    Dezzutti, Charlene S.
    Boczar, Ashlee D.
    Buckheit, Karen W.
    Buckheit, Robert W., Jr.
    ANTIVIRAL RESEARCH, 2015, 120 : 153 - 164
  • [50] Pregnancy Incidence and Risk Factors among Women Participating in Vaginal Microbicide Trials for HIV Prevention: Systematic Review and Meta-Analysis
    Musekiwa, Alfred
    Muchiri, Evans
    Manda, Samuel O. M.
    Mwambi, Henry G.
    PLOS ONE, 2013, 8 (10):